Testing effectiveness (Phase 2)Study completedNCT04993677What this trial is testingSEA-CD40 Given With Other Drugs in CancersWho this might be right forMelanomaCarcinoma, Non-Small- Cell Lung Seagen Inc. 77
Testing effectiveness (Phase 2)Study completedNCT03736837What this trial is testingStudy of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLCWho this might be right forNon Small Cell Lung Cancer Tianjin Medical University Cancer Institute and Hospital 60
Large-scale testing (Phase 3)Study completedNCT03607539What this trial is testingEfficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLCWho this might be right forLung Neoplasms Innovent Biologics (Suzhou) Co. Ltd. 397
Not applicableEnded earlyNCT00090961What this trial is testingS0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung CancerWho this might be right forLung CancerPulmonary Complications SWOG Cancer Research Network 2
Large-scale testing (Phase 3)Study completedNCT01005680What this trial is testingA Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 256
Large-scale testing (Phase 3)UnknownNCT03262948What this trial is testingNab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 388
Large-scale testing (Phase 3)Study completedNCT00005838What this trial is testingCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+3 more National Cancer Institute (NCI) 756
Testing effectiveness (Phase 2)Ended earlyNCT00093132What this trial is testingSatraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous RadiotherapyWho this might be right forCarcinoma, Non-small Cell LungLung Cancer Agennix 20
Early research (Phase 1)UnknownNCT03790228What this trial is testingAnlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLCWho this might be right forNon-squamous Cell Non-Small Cell Lung Cancer Henan Cancer Hospital 43
Not applicableStudy completedNCT02910999What this trial is testingReal-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 868
Early research (Phase 1)WithdrawnNCT00937417What this trial is testingS0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more SWOG Cancer Research Network
Early research (Phase 1)Ended earlyNCT03780725What this trial is testingThis Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091Who this might be right forCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms Boehringer Ingelheim 8
Testing effectiveness (Phase 2)Study completedNCT02250326What this trial is testingSafety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Celgene 240
Testing effectiveness (Phase 2)Study completedNCT05017025What this trial is testingAurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerWho this might be right forAdvanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more M.D. Anderson Cancer Center 32
Large-scale testing (Phase 3)Study completedNCT01082549What this trial is testingTrial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)Who this might be right forSquamous Cell Lung Cancer Sanofi 780
Testing effectiveness (Phase 2)Study completedNCT00006378What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerWho this might be right forLung Cancer Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT03565003What this trial is testingA First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in ChinaWho this might be right forNon-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more Jacobio Pharmaceuticals Co., Ltd. 126
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Post-approval studies (Phase 4)WithdrawnNCT03792503What this trial is testingPemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based RegimenWho this might be right forAdvanced Non-squamous Non-small-cell Lung Cancer Xinqiao Hospital of Chongqing
Early research (Phase 1)Study completedNCT03096054What this trial is testingA Phase I Trial of LY3143921 Hydrate in Solid TumoursWho this might be right forColorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more Cancer Research UK 69